Shuyuan Zhang joins VIRxSYS as senior director of production
This article was originally published in Scrip
Executive Summary
VIRxSYS, a private US biotechnology company focusing on the development of a lentiviral vector platform technology for the treatment of diseases such as HIV/AIDS and cancer, has appointed Dr Shuyuan Zhang senior director of production. Dr Zhang has more than 15 years' process development and GMP manufacture experience in the gene therapy industry; he has worked at Genetic Therapy, Introgen Therapeutics and Targeted Genetics.